GMAB vs SPY Stock Comparison

GMAB currently leads SPY in this stock comparison, with AIQ scores of 77 vs 63. The clearest difference is momentum, while SPY has the stronger risk resilience profile.

Market data as of Nov 15, 2026 market close· AIQ score gap 14 points
GMAB
Healthcare
vs
SPY
Equity
GMAB
Genmab A/S
Leads
Price
$51.37
Day move
-0.72%
AIQ Score
77/100
Best edge
Momentum
Sector
Healthcare
SPY
State Street SPDR S&P 500 ETF
Price
$754
Day move
-0.36%
AIQ Score
63/100
Best edge
Risk Resilience
Sector
Equity

What is the main difference between GMAB and SPY?

GMAB leads the current stock comparison as Genmab A/S, with the clearest separation coming from momentum and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

Genmab A/S vs State Street SPDR S&P 500 ETF

Data as of Nov 15, 2026· market close· GMAB (stock) vs SPY (ETF)· Coverage 65/66 fields· 42/42 directly comparable· Moderate confidence
AIQ VerdictCompetitiveAIQ Comparison Conviction 7/10

GMAB leads

GMAB leads by 14 AIQ points, primarily on Momentum and Value, and the lead has widened from 7 points over 30 sessions.

Competitive: 3 of 4 evidence groups support GMAB, its lead is widening, and its current signal state is conflicted.

Evidence agreement: 3 of 4Comparison trend: Strengthening
GMAB

Genmab A/S

Leads
AIQ Score
77/100
AIQ Edge Score
10/10
SPY

State Street SPDR S&P 500 ETF

AIQ Score
63/100
AIQ Edge Score
8/10

The Algovestiq AIQ Score currently favors GMAB over SPY, 77 versus 63 as of Nov 15, 2026. GMAB's advantage is driven primarily by stronger momentum and value, while SPY holds the stronger risk resilience profile. GMAB also shows the stronger technical structure relative to its 50-day moving average. 3 of 4 covered evidence groups favor GMAB today, and the comparison is rated Competitive on stability: the leader is throwing conflicting signals. GMAB lead: Strengthening — the AIQ differential moved from 7 to 14 points over 30 sessions.

Compare Genmab A/S and State Street SPDR S&P 500 ETF across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Total return with distributions reinvested, from daily closes.

GMAB
+20.6%
SPY
+72.3%

Total return comparison

Growth of $10,000, distributions reinvested

GMAB $12,062 · SPY $17,232

Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.

Compare GMAB and SPY against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

GMAB advantage
0
SPY advantage
  • Momentum94 vs 59
    GMAB +35
  • Value71 vs 37
    GMAB +34
  • Risk Resilience58 vs 72
    SPY +14
  • Quality72 vs 79
    SPY +7

3 of 4 evidence groups favor GMAB. GMAB’s edge is concentrated in momentum and value; SPY keeps a meaningful risk resilience edge.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

GMAB-1 AIQ

No factor moved materially.

New signals

  • Low Volume Rally Warning — bearish, volume, short horizon (0.57x)
SPY+1 AIQ

Largest factor move: Risk Resilience -1

No signal started or stopped since the prior session; its 5 active signals are unchanged.

GMAB's lead narrowed by 2 AIQ points in the latest session.

Deeper signal detail for each name lives on its own signals page — GMAB and SPY both carry a full feed there.

The central trade-off

GMAB (Genmab A/S): the stronger current systematic profile, led by momentum and value.

SPY (State Street SPDR S&P 500 ETF): the counter-case, on risk resilience, quality.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

GMAB

GMAB on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

Even

Growth figures are not covered for both names.

Value

GMAB

GMAB on the peer-relative Value factor, by 34 points.

Momentum

GMAB

GMAB on the Momentum factor, by 35 points.

Lower downside

SPY

SPY on Risk Resilience, by 14 points.

Analyst upside

Even

Analyst targets are level or not covered for both names.

AIQ vs Wall Street

Where the systematic read and the analyst consensus line up — and where they do not.

MeasureGMABSPYNote
Implied upside to target+8%—Level
Target dispersion+50.5%—Lower is tighter analyst agreement
ConsensusBuy—Context, not a primary driver
Analysts covering13—Higher coverage generally improves confidence

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

3 of 4 covered evidence groups favor GMAB. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreGMAB77 vs 63
FundamentalsNot coveredNot covered
ValuationGMABValue 71 vs 37
TechnicalsGMABPrice vs 50-day 24.8% vs -1.3%; vs 200-day 62.9% vs 3.1%
Risk ResilienceSPYRisk Resilience 58 vs 72
Analyst expectationsNot coveredNot covered

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of GMAB and SPY and are excluded from the count.

AIQ Decision Stability

Competitive

The two are close enough that your objective, not the score, should decide.

  • The AIQ gap is wide at 14 points. (supports the conclusion holding)
  • The leader's advantage has been widening. (supports the conclusion holding)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on GMAB.

How the comparison changed

120 daily snapshots · May 27 – Nov 13

GMAB lead: Strengthening — the AIQ differential moved from 7 to 14 points over 30 sessions.

May 27GMAB leads above the line · SPY leads belowNov 13
Today
GMAB +14
77 vs 63
7 sessions ago
GMAB +14
79 vs 65
30 sessions ago
GMAB +7
77 vs 70
90 sessions ago
GMAB +3
68 vs 65

The lead has not changed hands in this window.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

GMABConflicted

3 bullish / 3 bearish / 1 neutral, conflicted

Only GMAB

  • ATR Expansion - Breakout Mode — neutral, volatility, short horizon (4.51%)
  • EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
  • Low Volume Rally Warning — bearish, volume, short horizon (0.57x)
  • MACD Histogram Expanding Bearish — bearish, momentum, short horizon
  • RSI Bearish Divergence — bearish, momentum, medium horizon
  • Uptrend Structure Active — bullish, trend, long horizon
SPY

2 bullish / 0 bearish / 3 neutral

Only SPY

  • Bollinger Band Squeeze — neutral, volatility, short horizon (5.9%)
  • 52-Week High Proximity — bullish, risk_regime, long horizon (2.8%)
  • ADX Trend Weakening — neutral, trend, medium horizon
  • ATR Contraction - Coiling — neutral, volatility, short horizon (1.46%)

Both carry 1 more signal that do not separate them: Golden Cross Active.

GMAB leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

GMABConfirmed weakness

Price and the AIQ Score both moved down over the latest session (price -0.72%, AIQ -1 points).

SPYDivergence

Price is down while the AIQ Score moved up 1 points over the same session — price and model disagree (price -0.36%, AIQ +1 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1SPY closes the Momentum gap — currently 35 points behind, the largest single contributor to GMAB's edge.
  2. 2SPY's Bollinger Band Squeeze turns directional — it is neutral today and would confirm a change in trend.
  3. 3GMAB's conflicting signal state resolves bearish — it currently carries 3 bullish and 3 bearish rules at once.
  4. 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

Split
MetricGMABSPY
Revenue growth (YoY)2.8%—
EPS growth (YoY)14.3%—
Gross margin92.6%—
Operating margin30.5%—
Return on equity (TTM)5.4%—
Debt to equity0.82—

Performance

GMAB leads 5 of 6 windows
MetricGMABSPY
1 week (5 sessions)-4.2%2.6%
1 month (20 sessions)38.8%-1.2%
3 months (63 sessions)56.4%-2.4%
6 months (126 sessions)93.6%2.1%
Year to date66.8%10.6%
1 year (252 sessions)68.6%10.4%

Technicals

GMAB has the stronger structure
MetricGMABSPY
RSI (14)59.147.1
ADX (14)45.814.2
Price vs 50-day24.8%-1.3%
Price vs 200-day62.9%3.1%
Volatility (1M, annualized)110.9%22.1%

Risk

SPY is the more resilient
MetricGMABSPY
Beta0.931
Sharpe ratio1.290.63
Sortino ratio2.530.89
Max drawdown-32.5%-9.1%
Current drawdown-10.3%-3.2%
Annualized volatility45.9%13.6%
Value at risk (95%)-3.2%-1.4%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, GMAB or SPY?

On the Algovestiq AIQ Score, GMAB is the stronger of the two as of Nov 15, 2026, scoring 77 against SPY's 63. The edge comes from momentum and value. SPY is not without a case — it holds the better risk resilience profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is GMAB or SPY the better buy right now?

GMAB carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Competitive — 3 of 4 covered evidence groups agree. A Competitive rating means the two are close enough that your objective, not the score, should decide.

Why does the AIQ Score favor GMAB over SPY?

The composite weights Quality, Value, Momentum and Risk Resilience. GMAB leads Momentum by 35 points; GMAB leads Value by 34 points; SPY leads Risk Resilience by 14 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, GMAB or SPY?

Analyst price targets imply +8% upside for GMAB and not covered for SPY. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, GMAB or SPY?

GMAB is the better-valued of the two on the peer-relative Value factor. GMAB on the peer-relative Value factor, by 34 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, GMAB or SPY?

Growth figures are not covered for both names. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, GMAB or SPY?

GMAB on the Momentum factor, by 35 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, GMAB or SPY?

SPY is the more resilient of the two, so the other name carries the higher downside risk. SPY on Risk Resilience, by 14 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is GMAB more profitable than SPY?

Margin data is not comparable for both names in the current snapshot.

Is GMAB's lead over SPY getting stronger or weaker?

GMAB lead: Strengthening — the AIQ differential moved from 7 to 14 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has not changed hands in that window.

What would change the GMAB vs SPY verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: SPY closes the Momentum gap — currently 35 points behind, the largest single contributor to GMAB's edge; SPY's Bollinger Band Squeeze turns directional — it is neutral today and would confirm a change in trend; GMAB's conflicting signal state resolves bearish — it currently carries 3 bullish and 3 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

What do the current signals say about GMAB and SPY?

GMAB: 3 bullish / 3 bearish / 1 neutral, conflicted. SPY: 2 bullish / 0 bearish / 3 neutral. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on GMAB is Golden Cross Active (bullish, long horizon). On SPY it is Golden Cross Active (bullish, long horizon).

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.